Skip to main content

Main menu

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Blog
    • Collections
    • Podcast
  • TOPICS
    • Cognition and Behavior
    • Development
    • Disorders of the Nervous System
    • History, Teaching and Public Awareness
    • Integrative Systems
    • Neuronal Excitability
    • Novel Tools and Methods
    • Sensory and Motor Systems
  • ALERTS
  • FOR AUTHORS
  • ABOUT
    • Overview
    • Editorial Board
    • For the Media
    • Privacy Policy
    • Contact Us
    • Feedback
  • SUBMIT

User menu

Search

  • Advanced search
eNeuro
eNeuro

Advanced Search

 

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Blog
    • Collections
    • Podcast
  • TOPICS
    • Cognition and Behavior
    • Development
    • Disorders of the Nervous System
    • History, Teaching and Public Awareness
    • Integrative Systems
    • Neuronal Excitability
    • Novel Tools and Methods
    • Sensory and Motor Systems
  • ALERTS
  • FOR AUTHORS
  • ABOUT
    • Overview
    • Editorial Board
    • For the Media
    • Privacy Policy
    • Contact Us
    • Feedback
  • SUBMIT
PreviousNext
Research ArticleFailure to Replicate, Neuronal Excitability

Limited Efficacy of α-Conopeptides, Vc1.1 and RgIA, To Inhibit Sensory Neuron CaV Current

Andrew B. Wright, Yohei Norimatsu, J. Michael McIntosh and Keith S. Elmslie
eNeuro 16 January 2015, 2 (1) ENEURO.0057-14.2015; https://doi.org/10.1523/ENEURO.0057-14.2015
Andrew B. Wright
1The Baker Laboratory of Pharmacology, Department of Pharmacology, Kirksville College of Osteopathic Medicine, at Still University of Health Sciences, Kirksville, Missouri 63501
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yohei Norimatsu
2 Department of Physiology, Kirksville College of Osteopathic Medicine, at Still University of Health Sciences, Kirksville, Missouri 63501
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J. Michael McIntosh
3 George E. Wahlen Veterans Affairs Medical Center and Departments of Psychiatry and Biology, University of Utah, Salt Lake City, Utah 84148
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Keith S. Elmslie
1The Baker Laboratory of Pharmacology, Department of Pharmacology, Kirksville College of Osteopathic Medicine, at Still University of Health Sciences, Kirksville, Missouri 63501
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

DOI 
https://doi.org/10.1523/ENEURO.0057-14.2015
PubMed 
26078999
Published By 
Society for Neuroscience
History 
  • Received November 18, 2014
  • Revision received January 7, 2015
  • Accepted January 14, 2015
  • Published online January 16, 2015.
Copyright & Usage 
Copyright © 2014 Wright et al. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International, which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.

Author Information

  1. Andrew B. Wright1,
  2. Yohei Norimatsu2,
  3. J. Michael McIntosh3 and
  4. Keith S. Elmslie1
  1. 1The Baker Laboratory of Pharmacology, Department of Pharmacology, Kirksville College of Osteopathic Medicine, at Still University of Health Sciences, Kirksville, Missouri 63501
  2. 2 Department of Physiology, Kirksville College of Osteopathic Medicine, at Still University of Health Sciences, Kirksville, Missouri 63501
  3. 3 George E. Wahlen Veterans Affairs Medical Center and Departments of Psychiatry and Biology, University of Utah, Salt Lake City, Utah 84148
  1. Correspondence should be addressed to Keith S. Elmslie, Department of Pharmacology, AT Still University of Health Sciences, Kirskville College of Osteopathic Medicine, 800 W. Jefferson Street, Kirksville, MO 63501. E-mail: kelmslie{at}atsu.edu.
View Full Text

Author contributions

  1. ↵2 Author contributions: A.B.W., Y.N., J.M.M., and K.S.E. designed research; A.B.W., Y.N., and K.S.E. performed research; J.M.M. contributed unpublished reagents/analytic tools; A.B.W., Y.N., and K.S.E. analyzed data; A.B.W., Y.N., J.M.M., and K.S.E. wrote the paper.

View Abstract

Disclosures

  • ↵1 The authors declare no competing financial interests.

  • ↵3 The funding for this work came from NIH Grants GM48677, GM103801 (J.M.M.), and AR59397 (K.S.E.). The University of Utah holds patents on α-conotoxin RgIA, of which J. Michael McIntosh is listed as an inventor. We thank Doju Yoshikami for critical reading of the manuscript.

Funding

  • NIH NIGMS

    GM48677
  • NIH NIGMS

    GM103801
  • NIH NIAMS

    AR59397

Other Version

  • You are viewing the most recent version of this article.
  • previous version (January 16, 2015).
  • previous version (January 16, 2015).

Online Impact

 

Article usage

Select a custom date range for the past year
E.g., 2025-06-22
to
E.g., 2025-06-22

Article usage: June 2016 to May 2025

AbstractFullPdf
Jun 2016072
Jul 2016044
Aug 2016032
Sep 20160103
Oct 20160101
Nov 2016073
Dec 2016040
Total 201604515
Jan 2017047
Feb 2017082
Mar 2017081
Apr 20176910
May 2017145
Jun 2017365
Jul 2017157
Aug 201792111
Sep 201787910
Oct 201715428
Nov 2017112911
Dec 201710186
Total 201750245103
Jan 2018122119
Feb 201820128
Mar 201852214
Apr 2018103718
May 2018213511
Jun 201883717
Jul 20182459
Aug 201884617
Sep 20183408
Oct 201889121
Nov 201892139
Dec 2018122032
Total 2018118802153
Jan 2019101818
Feb 201971788
Mar 20194575
Apr 201982918
May 20192136
Jun 20194197
Jul 201964813
Aug 201952911
Oct 2019080
Nov 201951911
Dec 20192167
Total 20195359794
Jan 20207248
Feb 202011420
Mar 2020176
May 20202139
Jun 202011611
Jul 20202289
Aug 202071916
Sep 202023310
Oct 202076411
Nov 202074020
Dec 20207669
Total 202044324129
Jan 202114711
Feb 20211342
Mar 20215455
Apr 202174510
May 20215433
Jun 20210479
Jul 202124911
Aug 202174719
Sep 20210389
Oct 202134620
Nov 202125228
Dec 20210436
Total 202133536133
Jan 202244314
Feb 20222289
Mar 202254116
Apr 20222265
May 202234531
Jun 202214112
Jul 20223457
Aug 20223282
Sep 202272822
Oct 202233318
Nov 202243523
Dec 202255719
Total 202242450178
Jan 202306413
Feb 20235448
Mar 20232373
Apr 20232408
May 202323523
Jun 20233368
Jul 202314432
Aug 202344017
Sep 20236427
Oct 202325610
Nov 20234404
Dec 202357811
Total 202336556144
Jan 2024285810
Feb 20244415
Mar 202495016
Apr 202485618
May 202455313
Jun 202456110
Jul 202474215
Aug 202454111
Sep 202454910
Oct 20241367
Nov 202455111
Dec 202403910
Total 202482577136
Jan 202535317
Feb 202568225
Mar 202566143
Apr 202545029
May 202553712
Total 202524283126
Total48244151211
Back to top

In this issue

eneuro: 2 (1)
eNeuro
Vol. 2, Issue 1
January/February 2015
  • Table of Contents
  • Index by author
Email

Thank you for sharing this eNeuro article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Limited Efficacy of α-Conopeptides, Vc1.1 and RgIA, To Inhibit Sensory Neuron CaV Current
(Your Name) has forwarded a page to you from eNeuro
(Your Name) thought you would be interested in this article in eNeuro.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
View Full Page PDF
Citation Tools
Limited Efficacy of α-Conopeptides, Vc1.1 and RgIA, To Inhibit Sensory Neuron CaV Current
Andrew B. Wright, Yohei Norimatsu, J. Michael McIntosh, Keith S. Elmslie
eNeuro 16 January 2015, 2 (1) ENEURO.0057-14.2015; DOI: 10.1523/ENEURO.0057-14.2015

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Share
Limited Efficacy of α-Conopeptides, Vc1.1 and RgIA, To Inhibit Sensory Neuron CaV Current
Andrew B. Wright, Yohei Norimatsu, J. Michael McIntosh, Keith S. Elmslie
eNeuro 16 January 2015, 2 (1) ENEURO.0057-14.2015; DOI: 10.1523/ENEURO.0057-14.2015
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Significance Statement
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Footnotes
    • References
    • Synthesis
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Keywords

  • alpha9/alpha10 AChR Current
  • Analagesic Mechanisms
  • Baclofen
  • CaV2.2 Current
  • Rat Sensory Neurons

Responses to this article

Respond to this article

Jump to comment:

No eLetters have been published for this article.

Related Articles

Cited By...

More in this TOC Section

Failure to Replicate

  • Experimental Design and Data Analysis Issues Contribute to Inconsistent Results of C-Bouton Changes in Amyotrophic Lateral Sclerosis
  • Levels of Cocaine- and Amphetamine-Regulated Transcript in Vagal Afferents in the Mouse Are Unaltered in Response to Metabolic Challenges
Show more Failure to Replicate

Neuronal Excitability

  • Experimental Design and Data Analysis Issues Contribute to Inconsistent Results of C-Bouton Changes in Amyotrophic Lateral Sclerosis
  • Levels of Cocaine- and Amphetamine-Regulated Transcript in Vagal Afferents in the Mouse Are Unaltered in Response to Metabolic Challenges
  • Investigating Mechanically Activated Currents from Trigeminal Neurons of Nonhuman Primates
Show more Neuronal Excitability

Subjects

  • Neuronal Excitability
  • Home
  • Alerts
  • Follow SFN on BlueSky
  • Visit Society for Neuroscience on Facebook
  • Follow Society for Neuroscience on Twitter
  • Follow Society for Neuroscience on LinkedIn
  • Visit Society for Neuroscience on Youtube
  • Follow our RSS feeds

Content

  • Early Release
  • Current Issue
  • Latest Articles
  • Issue Archive
  • Blog
  • Browse by Topic

Information

  • For Authors
  • For the Media

About

  • About the Journal
  • Editorial Board
  • Privacy Notice
  • Contact
  • Feedback
(eNeuro logo)
(SfN logo)

Copyright © 2025 by the Society for Neuroscience.
eNeuro eISSN: 2373-2822

The ideas and opinions expressed in eNeuro do not necessarily reflect those of SfN or the eNeuro Editorial Board. Publication of an advertisement or other product mention in eNeuro should not be construed as an endorsement of the manufacturer’s claims. SfN does not assume any responsibility for any injury and/or damage to persons or property arising from or related to any use of any material contained in eNeuro.